Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting

被引:27
作者
Rosow, Carl E. [1 ]
Haspel, Kenneth L. [2 ]
Smith, Sarah E. [3 ]
Grecu, Loreta [1 ]
Bittrier, Edward A. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA
[2] Yale Univ, Sch Med, Dept Anesthesiol, Boston, MA USA
[3] Boston Univ, Sch Med, Boston, MA 02118 USA
关键词
D O I
10.1213/ane.0b013e3181609022
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
BACKGROUND: Haloperidol is effective for postoperative nausea and vomiting prophylaxis, but there are almost no data comparing it to 5-HT3 antagonists. METHODS: Two hundred forty-four adults were randomized to receive IV haloperidol 1 mg or ondansetron 4 mg, during general anesthesia. Nausea, vomiting, need for rescue, sedation, extrapyramidal effects, QTc intervals, and time to postanesthesia care unit discharge were evaluated with a third-party blind design. RESULTS: There was no intergroup difference in any measure of efficacy or toxicity. Haloperidol and ondansetron subjects (78.2% and 76.8%) had complete response. Postoperatively, prolonged QTc occurred in 28.9% and 22.1% (N.S.). CONCLUSIONS: In a mixed surgical population, the efficacy and toxicity of postoperative nausea and vomiting prophylaxis with haloperidol I mg was not significantly different from ondansetron 4 mg.
引用
收藏
页码:1407 / 1409
页数:3
相关论文
共 13 条
[1]
Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery [J].
Aouad, M. T. ;
Siddik-Sayyid, S. M. ;
Taha, S. K. ;
Azar, M. S. ;
Nasr, V. G. ;
Hakki, M. A. ;
Zoorob, D. G. ;
Baraka, A. S. .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2007, 24 (02) :171-178
[2]
USE OF HALOPERIDOL FOR TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING - DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL [J].
BARTON, MD ;
LIBONATI, M ;
COHEN, PJ .
ANESTHESIOLOGY, 1975, 42 (04) :508-512
[3]
Büttner M, 2004, ANESTHESIOLOGY, V101, P1454
[4]
BYHAHN C, 2003, ANESTHESIOLOGY, V99, pA1289
[6]
Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting [J].
Eberhart, LHJ ;
Mauch, M ;
Morin, AM ;
Wulf, H ;
Geldner, G .
ANAESTHESIA, 2002, 57 (10) :1022-1027
[7]
FISCHLER M, 1986, ANESTHESIOLOGY, V64, P486
[8]
PHARMACOKINETICS OF HALOPERIDOL [J].
FROEMMING, JS ;
LAM, YWF ;
JANN, MW ;
DAVIS, CM .
CLINICAL PHARMACOKINETICS, 1989, 17 (06) :396-423
[9]
NEIDHART JA, 1981, CANCER-AM CANCER SOC, V47, P1439, DOI 10.1002/1097-0142(19810315)47:6<1439::AID-CNCR2820470633>3.0.CO
[10]
2-#